retatrutide trial results news π¨ TRIUMPH-1 Phase 3 top-line results, much awaited and just announced β¬οΈ 28.3% Weight loss at 80 weeks β¬οΈ 30.3% weight loss at 104 weeks among adults with baseline BMI >35 Retatrutide Commercial Availability Timeline: Key
Description
Dashboard metrics can include fewer ER visits and decreased use of other medications as members lose weight

Expected Approval Timeline Retatrutide is still in clinical development

Tirzepatide copies two hormones: GLP-1 and GIP

But I like this restoring homeostasis
